supervised, hypertrophy-oriented strength training program
supervised, hypertrophy-oriented strength training program: 12-week supervised, hypertrophy-oriented strength training program in preserving skeletal muscle mass
Study summary
To determine the efficacy of a 12-week supervised, hypertrophy-oriented strength training program in preserving skeletal muscle mass, physical function, and quality of life in patients with unresectable pancreatic cancer compared to standard care.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Diagnosis of locally advanced or metastatic unresectable pancreatic cancer
* Undergoing chemotherapy or immunotherapy treatment
* Age ≥ 18 years
* ECOG score ≤ 2
Exclusion Criteria:
* Any relative or absolute contraindication that prevents the performance of training or physical tests.
* Diagnosis of other types of primary cancer
* Inability to understand Spanish for proper comprehension of the informed consent and questionnaires
Primary outcome measure(s)
Body Composition — Through study completion, an average of 1 year The main objective of this study is to evaluate the effect on body composition (primarily lean mass) through 12 weeks of hypertrophy training in patients with advanced, non-operable pancreatic cancer undergoing treatment
Trial sites (1)
Facility
City
Region
Status
Universidad Europea de Madrid
Madrid
Madrid
More Universidad Europea de Madrid trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
